BioMarin Pharmaceutical Inc.
BMRN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,250,108 | $1,213,816 | $1,048,803 | $942,842 |
| Short-Term Investments | $227,731 | $218,309 | $223,532 | $194,864 |
| Receivables | $790,266 | $855,855 | $739,177 | $660,535 |
| Inventory | $1,382,173 | $1,340,169 | $1,274,848 | $1,232,653 |
| Other Curr. Assets | $204,265 | $177,183 | $181,545 | $201,533 |
| Total Curr. Assets | $3,854,543 | $3,805,332 | $3,467,905 | $3,232,427 |
| Property Plant & Equip (Net) | $1,038,187 | $1,030,385 | $1,032,613 | $1,043,041 |
| Goodwill | $196,199 | $196,199 | $196,199 | $196,199 |
| Intangibles | $233,112 | $239,620 | $247,346 | $255,278 |
| Long-Term Investments | $512,937 | $508,592 | $506,724 | $521,238 |
| Tax Assets | $1,509,109 | $1,427,021 | $1,460,566 | $1,489,366 |
| Other NC Assets | $270,781 | $249,192 | $235,654 | $251,391 |
| Total NC Assets | $3,760,325 | $3,651,009 | $3,679,102 | $3,756,513 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,614,868 | $7,456,341 | $7,147,007 | $6,988,940 |
| Liabilities | – | – | – | – |
| Payables | $389,670 | $310,797 | $293,751 | $235,403 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $13,401 | $23,942 | $12,567 |
| Deferred Revenue | $0 | $0 | $0 | $1,369 |
| Other Curr. Liab. | $386,162 | $174,719 | $145,743 | $215,569 |
| Total Curr. Liab. | $798,438 | $684,247 | $628,213 | $606,988 |
| LT Debt | $596,663 | $596,162 | $595,650 | $595,138 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $163,056 | $148,819 | $129,685 | $128,824 |
| Total NC Liab. | $759,719 | $744,981 | $725,335 | $723,962 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $7,704 | $6,309 | $7,574 |
| Total Liabilities | $1,558,157 | $1,429,228 | $1,353,548 | $1,330,950 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $192 | $192 | $192 | $191 |
| Retained Earnings | $200,779 | $231,523 | -$9,009 | -$194,695 |
| AOCI | -$45,228 | -$44,565 | $19,151 | $61,653 |
| Other Equity | $0 | -$11,674 | -$11,177 | -$11,227 |
| Total Equity | $6,056,711 | $6,027,113 | $5,793,459 | $5,657,990 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,614,868 | $7,456,341 | $7,147,007 | $6,988,940 |
| Net Debt | -$653,445 | -$617,654 | -$453,153 | -$347,704 |